Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Non-Current Assets (2017 - 2025)

Q32 Bio (QTTB) has 9 years of Non-Current Assets data on record, last reported at $6.7 million in Q4 2025.

  • For Q4 2025, Non-Current Assets fell 35.67% year-over-year to $6.7 million; the TTM value through Dec 2025 reached $35.4 million, down 26.19%, while the annual FY2025 figure was $6.7 million, 35.67% down from the prior year.
  • Non-Current Assets reached $6.7 million in Q4 2025 per QTTB's latest filing, down from $7.8 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $228.7 million in Q4 2022 and bottomed at $6.7 million in Q4 2025.
  • Average Non-Current Assets over 5 years is $41.0 million, with a median of $38.0 million recorded in 2023.
  • Peak YoY movement for Non-Current Assets: skyrocketed 1054.58% in 2022, then crashed 85.96% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $19.8 million in 2021, then surged by 1054.58% to $228.7 million in 2022, then plummeted by 67.45% to $74.5 million in 2023, then plummeted by 85.96% to $10.5 million in 2024, then tumbled by 35.67% to $6.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $6.7 million in Q4 2025, $7.8 million in Q2 2025, and $10.4 million in Q1 2025.